80_FR_67983 80 FR 67771 - Center for Scientific Review; Notice of Closed Meetings

80 FR 67771 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 212 (November 3, 2015)

Page Range67771-67772
FR Document2015-27983

Federal Register, Volume 80 Issue 212 (Tuesday, November 3, 2015) 
[Federal Register Volume 80, Number 212 (Tuesday, November 3, 2015)]
[Notices]
[Pages 67771-67772]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-27983]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel PAR-13-055: Dissemination and Implementation Research in 
Health.
    Date: November 20, 2015.
    Time: 11:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Mark P Rubert, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-435-
1775, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Program Project: Cell Biology.
    Date: November 23-24, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: David Balasundaram, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 
20892, 301-435-1022, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Small Business: HIV/AIDS Innovative Research Applications.
    Date: November 24, 2015.
    Time: 11:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mark P. Rubert, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 
20892, 301-435-1775, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel PAR Panel: HIV and Viral Hepatitis Co-Infection.
    Date: December 1, 2015.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5207, Bethesda, MD 20892, 301-451-8754, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel MH16-100:

[[Page 67772]]

The Role of Exosomes in HIV Neuropathogenesis.
    Date: December 4, 2015.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Robert Freund, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435-
1050, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel PAR13-280: Program Project: Cellular Reprogramming, 
Pluripotency and Differentiation.
    Date: December 7-8, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Elena Smirnova, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD 
20892, 301-435-1236, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 29, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-27983 Filed 11-2-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices 67771 Food and Drug Administration, FDA, Bemidji Area Indian Health Service, 522 confidential trade secrets or commercial Atlanta District Office, 60 Eighth Street Minnesota Avenue NW., Room 119, property such as patentable material, NE., Atlanta, GA 30309 Bemidji, MN 56601 and personal information concerning Food and Drug Administration, FDA, New Billings Area Indian Health Service, 2900 individuals associated with the grant England District Office, One Montvale 4th Avenue North, Billings, MT 59101 Avenue, Stoneham, MA 02180 California Area Indian Health Service, 650 applications, the disclosure of which Food and Drug Administration, FDA, New Capitol Mall, Suite 7–100, Sacramento, would constitute a clearly unwarranted Jersey District Office, 10 Waterview CA 95814 invasion of personal privacy. Boulevard, 3rd Floor, Parsippany, NJ Great Plains Area IHS, Federal Building, Name of Committee: Center for Scientific 07054 115 Fourth Avenue, Southeast, Review Special Emphasis Panel PAR–13– Food and Drug Administration, FDA, Aberdeen, SD 57401 055: Dissemination and Implementation Philadelphia District Office, Room 900, Nashville Area Indian Health Service, 711 Research in Health. U.S. Customhouse, 2nd and Chestnut Stewarts Ferry Pike, Nashville, TN Date: November 20, 2015. Streets, Philadelphia, PA 19106 37214–2634 Time: 11:30 a.m. to 3:00 p.m. Food and Drug Administration, FDA, Navajo Area Indian Health Service, P.O. Agenda: To review and evaluate grant Baltimore District Office, 6000 Metro Box 9020, Window Rock, AZ 86515– applications. Drive, Suite 101, Baltimore, MD 21215 9020 Place: National Institutes of Health, 6701 Food and Drug Administration, FDA, San Oklahoma City Area Indian Health Service, Rockledge Drive, Bethesda, MD 20892 Juan District Office, 466 Fernandez 701 Market Dr., Oklahoma City, OK (Telephone Conference Call). Juncos Avenue, San Juan, PR 00901– 73114 Contact Person: Mark P Rubert, Ph.D., 3223 Phoenix Area Indian Health Service, Two Scientific Review Officer, Center for Food and Drug Administration, FDA, Renaissance Square, 40 North Central Scientific Review, National Institutes of Chicago District Office, 550 W. Jackson Avenue, Phoenix, AZ 85004–4424 Health, 6701 Rockledge Drive, Room 5218, Boulevard, Suite 1500 South, Chicago, IL Portland Area Indian Health Service, 1414 MSC 7852, Bethesda, MD 20892, 301–435– 606601 NW Northrup Street, Suite 800, Portland, 1775, rubertm@csr.nih.gov. Food and Drug Administration, FDA, OR 97209 Name of Committee: Center for Scientific Cincinnati District Office, 6751 Steger Tucson Area Indian Health Service, 7900 Review Special Emphasis Panel Program Drive, Cincinnati, OH 45237–3097 S.J. Stock Road, Tucson, AZ 85746–7012 Project: Cell Biology. Food and Drug Administration, FDA, National Institutes of Health (NIH) Date: November 23–24, 2015. Minneapolis District Office, 250 National Institutes of Health (NIH), Office Time: 8:00 a.m. to 5:00 p.m. Marquette Avenue, Suite 600, of the Director (OD), Office of Agenda: To review and evaluate grant Minneapolis, MN 55401 Management (OM), Office of Financial applications. Food and Drug Administration, FDA, Management (OFM), 2115 East Jefferson Place: National Institutes of Health, 6701 Dallas District Office, 4040 N. Central Street, Rockville, MD 20892–8500 Rockledge Drive, Bethesda, MD 20892 Expressway, Suite 300, Dallas, TX 75204 Program Support Center (PSC) (Virtual Meeting). Food and Drug Administration, FDA, Program Support Center (PSC) Division of Contact Person: David Balasundaram, Southwest Import District, 4040 N. Fiscal Operations, 5600 Fishers Lane, Ph.D., Scientific Review Officer, Center for Central Expressway, Suite 300, Dallas, Room 16–05, Rockville, MD 20857 Scientific Review, National Institutes of TX 75204 PSC serves as the finance center for these Health, 6701 Rockledge Drive, Room 5189, Food and Drug Administration, FDA, New HHS components: MSC 7840, Bethesda, MD 20892, 301–435– Orleans District Office, 6600 Plaza Drive, 1. Office of the Secretary (OS) 1022, balasundaramd@csr.nih.gov. Suite 400, New Orleans, LA 70127 2. Administration for Children and Name of Committee: Center for Scientific Food and Drug Administration, FDA, Families (ACF) Review Special Emphasis Panel Small Kansas City District Office, 8050 3. Administration for Community Living Business: HIV/AIDS Innovative Research Marshall Drive, Suite 205, Lenexa, KS (ACL) Applications. 66214 4. Agency for Healthcare Research and Date: November 24, 2015. Food and Drug Administration, FDA, Quality (AHRQ) Time: 11:30 a.m. to 2:30 p.m. Denver District Office, 6th Avenue & 5. Health Resources and Services Agenda: To review and evaluate grant Kipling St., Building 20, Denver Federal Administration (HRSA) applications. Center, Denver, CO 80225–0087 6. Office of Inspector General (OIG) Place: National Institutes of Health, 6701 Food and Drug Administration, FDA, 7. Substance Abuse and Mental Health Rockledge Drive, Bethesda, MD 20892 Florida District Office, 555 Winderly Services Administration (SAMHSA) (Virtual Meeting). Place, Suite 200, Maitland, FL 32751 Contact Person: Mark P. Rubert, Ph.D., [FR Doc. 2015–27980 Filed 11–2–15; 8:45 am] Scientific Review Officer, Center for Food and Drug Administration, FDA, San Francisco District Office, 1431 Harbor BILLING CODE 4150–24–P Scientific Review, National Institutes of Bay Parkway, Alameda, CA 94502–7096 Health, 6701 Rockledge Drive, Room 5218, Food and Drug Administration, FDA, Los MSC 7852, Bethesda, MD 20892, 301–435– Angeles District Office, 19701 Fairchild, DEPARTMENT OF HEALTH AND 1775, rubertm@csr.nih.gov. Irvine, CA 92612–2506 HUMAN SERVICES Name of Committee: Center for Scientific Food and Drug Administration, FDA, New Review Special Emphasis Panel PAR Panel: York District Office, 158–15 Liberty National Institutes of Health HIV and Viral Hepatitis Co-Infection. Avenue, Jamaica, NY 11433–1034 Date: December 1, 2015. Food and Drug Administration, FDA, Center for Scientific Review; Notice of Time: 1:00 p.m. to 5:00 p.m. Seattle District Office, 22215 26th Ave Closed Meetings Agenda: To review and evaluate grant SE., Suite 210, Bothell, WA 98021 applications. Food and Drug Administration, FDA, Pursuant to section 10(d) of the Place: National Institutes of Health, 6701 Headquarters Office, 10903 New Federal Advisory Committee Act, as Rockledge Drive, Bethesda, MD 20892 Hampshire Avenue, Silver Spring, MD (Telephone Conference Call). mstockstill on DSK4VPTVN1PROD with NOTICES amended (5 U.S.C. App.), notice is 20993 Contact Person: Jingsheng Tuo, Ph.D., hereby given of the following meetings. Scientific Review Officer, Center for Indian Health Service (IHS) The meetings will be closed to the Scientific Review, National Institutes of Alaska Area Indian Health Service, 4141 Ambassador Drive, Anchorage, AK public in accordance with the Health, 6701 Rockledge Drive, Room 5207, 99508–5928 provisions set forth in sections Bethesda, MD 20892, 301–451–8754, tuoj@ Albuquerque Area Indian Health Service, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., nei.nih.gov. 5300 Homestead Road NE., Albuquerque, as amended. The grant applications and Name of Committee: Center for Scientific NM 87109–1311 the discussions could disclose Review Special Emphasis Panel MH16–100: VerDate Sep<11>2014 18:04 Nov 02, 2015 Jkt 238001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\03NON1.SGM 03NON1

67772 Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices The Role of Exosomes in HIV Conflict: Neurodevelopmental and Scientific Review, National Institutes of Neuropathogenesis. Neurodegenerative Diseases. Health, 6701 Rockledge Drive, Room 5218, Date: December 4, 2015. Date: December 1, 2015. MSC 7852, Bethesda, MD 20892, 301–435– Time: 10:00 a.m. to 6:00 p.m. Time: 11:00 a.m. to 1:00 p.m. 1137, guerriej@csr.nih.gov. Agenda: To review and evaluate grant Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance applications. applications. Program Nos. 93.306, Comparative Medicine; Place: National Institutes of Health, 6701 Place: National Institutes of Health, 6701 93.333, Clinical Research, 93.306, 93.333, Rockledge Drive, Bethesda, MD 20892. Rockledge Drive, Bethesda, MD 20892 93.337, 93.393–93.396, 93.837–93.844, Contact Person: Robert Freund, Ph.D., (Telephone Conference Call). 93.846–93.878, 93.892, 93.893, National Scientific Review Officer, Center for Contact Person: Samuel C Edwards, Ph.D., Institutes of Health, HHS) Scientific Review, National Institutes of IRG CHIEF, Center for Scientific Review, Health, 6701 Rockledge Drive, Room 5216, National Institutes of Health, 6701 Rockledge Dated: October 28, 2015. MSC 7852, Bethesda, MD 20892, 301–435– Drive, Room 5210, MSC 7846, Bethesda, MD David Clary, 1050, freundr@csr.nih.gov. 20892, (301) 435–1246, edwardss@ Program Analyst, Office of Federal Advisory Name of Committee: Center for Scientific csr.nih.gov. Committee Policy. Review Special Emphasis Panel PAR13–280: Name of Committee: Center for Scientific [FR Doc. 2015–27933 Filed 11–2–15; 8:45 am] Program Project: Cellular Reprogramming, Review Special Emphasis Panel; BioCARS: Structural Dynamics and Biological BILLING CODE 4140–01–P Pluripotency and Differentiation. Date: December 7–8, 2015. Mechanisms. Time: 8:00 a.m. to 5:00 p.m. Date: December 1–3, 2015. Agenda: To review and evaluate grant Time: 5:00 p.m. to 11:00 a.m. DEPARTMENT OF HEALTH AND applications. Agenda: To review and evaluate grant HUMAN SERVICES Place: National Institutes of Health, 6701 applications. Rockledge Drive, Bethesda, MD 20892 Place: Argonne National Laboratory, 9700 National Institutes of Health (Virtual Meeting). South Cass Avenue, Lemont, IL 60439. Contact Person: Elena Smirnova, Ph.D., Contact Person: C–L Albert Wang, Ph.D., Center for Scientific Review; Notice of Scientific Review Officer, Center for Scientific Review Officer, Center for Closed Meetings Scientific Review, National Institutes of Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5187, Health, 6701 Rockledge Drive, Room 4146, Pursuant to section 10(d) of the MSC 7840, Bethesda, MD 20892, 301–435– MSC 7806, Bethesda, MD 20892, 301–435– Federal Advisory Committee Act, as 1236, smirnove@csr.nih.gov. 1016, wangca@csr.nih.gov. amended (5 U.S.C. App.), notice is (Catalogue of Federal Domestic Assistance Name of Committee: Center for Scientific hereby given of the following meetings. Program Nos. 93.306, Comparative Medicine; Review Special Emphasis Panel; Program The meetings will be closed to the Project: Biomedical Technology Research public in accordance with the 93.333, Clinical Research, 93.306, 93.333, Resource for NMR Spectroscopy. 93.337, 93.393–93.396, 93.837–93.844, provisions set forth in sections Date: December 1–3, 2015. 93.846–93.878, 93.892, 93.893, National 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 6:00 p.m. to 3:00 p.m. Institutes of Health, HHS) as amended. The grant applications and Agenda: To review and evaluate grant Dated: October 29, 2015. applications. the discussions could disclose Carolyn Baum, Place: Residence Inn Central Park, 1717 confidential trade secrets or commercial Program Analyst, Office of Federal Advisory Broadway (54th & Broadway), New York, NY property such as patentable material, Committee Policy. 10019. and personal information concerning Contact Person: Kee Hyang Pyon, Ph.D., individuals associated with the grant [FR Doc. 2015–27983 Filed 11–2–15; 8:45 am] Scientific Review Officer, Center for applications, the disclosure of which BILLING CODE 4140–01–P Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, would constitute a clearly unwarranted MSC 7806, Bethesda, MD 20892, pyonkh2@ invasion of personal privacy. DEPARTMENT OF HEALTH AND csr.nih.gov. Name of Committee: Center for Scientific HUMAN SERVICES Name of Committee: Center for Scientific Review Special Emphasis Panel; Rheumatoid Review Special Emphasis Panel; Member Arthritis and Imaging. National Institutes of Health Conflict: AIDS and AIDS Related Research. Date: November 20, 2015. Date: December 3, 2015. Time: 11 a.m. to 3 p.m. Center For Scientific Review; Notice of Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant Closed Meetings Agenda: To review and evaluate grant applications. applications. Place: National Institutes of Health, 6701 Pursuant to section 10(d) of the Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 Federal Advisory Committee Act, as Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). amended (5 U.S.C. App.), notice is (Virtual Meeting). Contact Person: Baljit S Moonga, Ph.D., hereby given of the following meetings. Contact Person: Shalanda A Bynum, Ph.D., Scientific Review Officer, Center for The meetings will be closed to the MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, public in accordance with the Health, 6701 Rockledge Drive Room 3206, MSC 7806, Bethesda, MD 20892, 301–435– provisions set forth in sections Bethesda, md 20892, 301–755–4355, 1777, moongabs@mail.nih.gov. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., bynumsa@csr.nih.gov. Name of Committee: Center for Scientific as amended. The grant applications and Name of Committee: Center for Scientific Review Special Emphasis Panel; Psycho/ the discussions could disclose Review Special Emphasis Panel; RFA Panel: Neuropathology, Lifespan Development, and confidential trade secrets or commercial Methodologies to Enhance Understanding of STEM Education. property such as patentable material, HIV Associated Social Determinants. Date: November 23, 2015. mstockstill on DSK4VPTVN1PROD with NOTICES and personal information concerning Date: December 4, 2015. Time: 2 p.m. to 6 p.m. individuals associated with the grant Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications, the disclosure of which Agenda: To review and evaluate grant applications. applications. Place: National Institutes of Health, 6701 would constitute a clearly unwarranted Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 invasion of personal privacy. Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting). Name of Committee: Center for Scientific Contact Person: Jose H Guerrier, Ph.D., Contact Person: John H Newman, Ph.D., Review Special Emphasis Panel; Member Scientific Review Officer, Center for Scientific Review Officer, Center for VerDate Sep<11>2014 18:04 Nov 02, 2015 Jkt 238001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\03NON1.SGM 03NON1


Document Created: 2018-03-01 11:33:09
Document Modified: 2018-03-01 11:33:09
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 20, 2015.
FR Citation80 FR 67771 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR